Mortality, cardiovascular risk and androgen deprivation therapy for prostate cancer. A systematic review with direct and network meta-analyses of randomized controlled trials and observational studies - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Fundamental & Clinical Pharmacology Année : 2016

Mortality, cardiovascular risk and androgen deprivation therapy for prostate cancer. A systematic review with direct and network meta-analyses of randomized controlled trials and observational studies

Domaines

Sciences du Vivant [q-bio]

Laurent Jonchère  : Connectez-vous pour contacter le contributeur

https://univ-rennes.hal.science/hal-01310756

Soumis le : mardi 3 mai 2016-10:18:38

Dernière modification le : mardi 12 décembre 2023-14:45:01

Fichier non déposé

Dates et versions

hal-01310756 , version 1 (03-05-2016)

Identifiants

  • HAL Id : hal-01310756 , version 1

Citer

L. M. Scailteux, Florian Naudet, Q. Alimi, S. Vindendeau, E Oger. Mortality, cardiovascular risk and androgen deprivation therapy for prostate cancer. A systematic review with direct and network meta-analyses of randomized controlled trials and observational studies. Fundamental & Clinical Pharmacology, 2016, 30, pp.7--7. ⟨hal-01310756⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UNIV-RENNES1 CIC CIC203 UR1-UFR-SVE UNIV-RENNES UR1-BIO-SA
46 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More